LIBRARY

Vol. 6, Issue 8

Volume 6, Issue 8

Pages 111–113

PDF
EDITORIAL
BOARD

Making a Digital Editorial Bridge between Birmingham, Alabama and Kyiv Stronger

Oleksii O. Tymofieieva, Ievgen I. Fesenkob more
a Oleksii O. Tymofieiev

Chief Editor, JDTOMP.

b Ievgen I. Fesenko

Managing Editor, JDTOMP. Corresponding author’s address: Editorial office, Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology (JDTOMP). 13-A Simferopolska Street, Kyiv 02096, Ukraine. E-mail: i.i.fesenko@dtjournal.org (Ievgen Fesenko)

August 25, 2022

J Diagn Treat Oral Maxillofac Pathol 2022;6: 111–3.

Under a Creative Commons license

HOW TO CITE THIS ARTICLE

Tymofieiev OO, Fesenko II. Making a digital editorial bridge between Birmingham, Alabama and Kyiv stronger. J Diagn Treat Oral Maxillofac Pathol 2022;6(8):111–3. https://doi.org/10.23999/j.dtomp.2022.8.1

ARTICLE

Maxillofacial Prosthetics, Dental Oncology, and things esthetically pleasing.1

―Michael T. Kase, DMD

Birmingham, Alabama, United States of America

 

Day by day, a new scholar bridge between Birmingham, Alabama and Kyiv becomes more tangible. The cornerstone of this digital bridge was laid by Dr. Le and colleagues in 2020.2 Their highly productive collaboration and hard work made this transatlantic cooperation possible.3,4 The interplay between the players of a team of any profile is a key aspect of its success. That is why cooperation with Dr. Kase (Fig), from the same Department of Oral and Maxillofacial Surgery as Dr. Le,2,3,5,6 became so important for the editorial board of the Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology.

FIGURE. Michael T. Kase, DMD―a new member of the editorial board.

Despite any circumstances, like pandemic7 and war8–11, the communication between professionals can show the tendency to grow. That is why we are so happy to feel the support of Dr. Kase in such a turbulent period as war time in Europe, and so proud seeing him the editorial board member of our journal.

 

Dr. Kase occupies several very responsible positions in his institution:

 

  • Associate Professor (from October 1, 2022), Department of Oral and Maxillofacial Surgery, Section of Oral Oncology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

  • Assistant and Clinical Director of the Advanced Education in Maxillofacial Prosthodontics and Dental Oncology Fellowship.

The doctor Kase’s work interests cover two directions―dental oncology and maxillofacial prosthodontics.2,3,5,6,12–16 Thus, such a unique expertise will definitely help our journal to fulfill the gap in the direction of maxillofacial prosthetics17 as a key part of head and neck oncologic surgery.

 

Thank you for this opportunity!

―Michael T. Kase, DMD

Email talk between Managing Editor with Dr. Kase

 

Dr. Kase’s email: mkase@uabmc.edu

Instagram page: @mikito7

REFERENCES (17)

  1. Instagram: @mikito7: Michael T. Kase, DMD [social media account on the internet]; 22 Aug 2022 [сited 22 Aug 2022]. Available from: Link

  2. Le JM, Chen PH, Seidenfaden JC, Morlandt AB, Kase MT. Zygomatic implants for restoration of complex nasal defects – a case report and outcome. J Diagn Treat Oral Maxillofac Pathol 2020;4(9):152–61. Crossref

  3. Le JM, Ying YP, Kase MT, Morlandt AB. Surgical reconstruction and rehabilitation of midface defects using osseointegrated implant-supported maxillofacial prosthetics. J Diagn Treat Oral Maxillofac Pathol 2022;6(1):9–25. Crossref

  4. Tymofieiev OO, Fesenko II. Meet the founding resident ambassador: John M. Le, DDS, MD. J Diagn Treat Oral Maxillofac Pathol 2022;6(1):3–5. Crossref

  5. Le JM, Gigliotti J, Ying Y, Kase MY, Morlandt AB. Computer-assisted microvascular free flap reconstruction and implant rehabilitation of the maxilla—treatment of a rare post-orthognathic complication. J Maxillofac Oral Surg 2021;21(1):82-87. Crossref

  6. Le JM, Kase MT, Morlandt AB. A case of dyskeratosis congenita with squamous cell carcinoma of the maxilla: a case report and review of the literature. Oral Maxillofac Surg Cases 2020;6(1):100140. Crossref

  7. Maffia F, Fesenko II, Vellone V. Covid-2019 pandemic: growing wave of cancelled meetings in oral and maxillofacial surgery and its impact on specialty. J Diagn Treat Oral Maxillofac Pathol 2020;4(8):125–8. Crossref

  8. Fesenko II. Stop the war! Europeans, homes, kindergartens, hospitals, universities, and global science are under the missiles. J Diagn Treat Oral Maxillofac Pathol 2022;6(2):32–4. Crossref

  9. Fernandes R, Susarla S, Parmar S. Implications of war and healthcare. Craniomaxillofac Trauma Reconstr 2022;15(2):97. Crossref

  10. van Aalst J. The costly yet valuable lessons of war. Face 2022;3(2):241–2. Crossref

  11. Stefánsdóttir Á. The medical oath in the times of war [in Icelandic]. Laeknabladid (Icel Med J) 2022;108(4):171. Crossref

  12. Chen PH, Seidenfaden JC, Kase MT, Sooudi I. Fabricating a partial nasal prosthesis with a custom nasal dilator design. J Prosthet Dent 2021;126(3):447–51. Crossref

  13. Chen PH, Seidenfaden JC, Sooudi I, Kase MT. Using digital technology to create a custom esthetic bandage for patients after rhinectomy. J Prosthet Dent 2021;125(2):357–60. Crossref

  14. Colebeck AC, Kase MT, Nichols CB, Golden M, Huryn JM. Use of orbital conformer to improve speech in patients with confluent maxillectomy and orbital defects. J Prosthodont 2016;25(3):241–6. Crossref

  15. Walma DAC, Seidenfaden JC, Mourad F, Kase MT. Prosthetic rehabilitation via silicone nasal prosthesis with internal alar support following partial rhinectomy: a short communication. Int J Prosthodont 2019;32(2):208–10. Crossref

  16. Gigliotti J, Ying Y, Redden D, Kase M, Morlandt AB. Fasciocutaneous flaps for refractory intermediate stage osteoradionecrosis of the mandible-is it time for a shift in management? J Oral Maxillofac Surg 2021;79(5):1156–67. Crossref

  17. Lee SKY. Getting to know today's maxillofacial prosthodontist. J Prosthet Dent 2022;127(3):381–2. Crossref